151 related articles for article (PubMed ID: 17670846)
1. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L; Ordi-Ros J; Balada E; Segarra-Medrano A; Majó-Masferrer J; Labrador-Horrillo M; Vilardell-Tarrés M
Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
[TBL] [Abstract][Full Text] [Related]
2. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
[TBL] [Abstract][Full Text] [Related]
3. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[TBL] [Abstract][Full Text] [Related]
4. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response.
Papadimitraki ED; Tzardi M; Bertsias G; Sotsiou E; Boumpas DT
Lupus; 2009 Aug; 18(9):831-5. PubMed ID: 19578108
[TBL] [Abstract][Full Text] [Related]
5. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
7. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
Marks SD; Williams SJ; Tullus K; Sebire NJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis.
Jeruc J; Vizjak A; Rozman B; Ferluga D
Am J Kidney Dis; 2006 Sep; 48(3):410-8. PubMed ID: 16931214
[TBL] [Abstract][Full Text] [Related]
9. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
10. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
Lu F; Shen W; Zhang X; Guo M; Lin S
Chin Med J (Engl); 2000 Dec; 113(12):1082-6. PubMed ID: 11776141
[TBL] [Abstract][Full Text] [Related]
12. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.
Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW
Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165
[TBL] [Abstract][Full Text] [Related]
13. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
[TBL] [Abstract][Full Text] [Related]
14. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
[TBL] [Abstract][Full Text] [Related]
15. The prognosis and pathogenesis of severe lupus glomerulonephritis.
Schwartz MM; Korbet SM; Lewis EJ;
Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
Kanno A; Hotta O; Yusa N; Taguma Y
Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
[TBL] [Abstract][Full Text] [Related]
17. High levels of complement C3a receptor in the glomeruli in lupus nephritis.
Mizuno M; Blanchin S; Gasque P; Nishikawa K; Matsuo S
Am J Kidney Dis; 2007 May; 49(5):598-606. PubMed ID: 17472841
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in diffuse proliferative lupus nephritis.
Abraham MA; Korula A; Jayakrishnan K; John GT; Thomas PP; Jacob CK
J Assoc Physicians India; 1999 Sep; 47(9):862-5. PubMed ID: 10778652
[TBL] [Abstract][Full Text] [Related]
19. Expression of proliferating cell associated protein, Ki-67, supports cellular proliferation in WHO Class IV lupus nephritis.
Cheah PL; Kunaseegaran R; Looi LM
Malays J Pathol; 2001 Jun; 23(1):27-30. PubMed ID: 16329544
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
